TRICYCLIC COMPOUNDS USEFUL AS ANGIOTENSIN II AGONISTS

Details for Australian Patent Application No. 2003205837 (hide)

Owner VICORE PHARMA AB.

Inventors HALLBERG, Anders; ALTERMAN, Mathias

Pub. Number AU-A-2003205837

PCT Number PCT/GB03/00375

PCT Pub. Number WO2003/064414

Priority 60/352,216 29.01.02 US

Filing date 29 January 2003

Wipo publication date 2 September 2003

International Classifications

C07D 409/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/437

A61K 031/4184

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/352,216 29.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003205837

14 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003205838-17-ALPHA-HETEROCYCLIC ESTERS OF ANDROSTANE DERIVATIVES HAVING ANTI-INFLAMMATORY ACTIVITY

2003205836-Use of 4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno(2, 3-d)-pyrimidine for treating of urinary incontinence